retrospective comparative study of concomitant chemoradiotherapy followed by adjuvant temozolomide versus radiotherapy alone in newly diagnosed Glioblastoma multiforme - an experience at Radium institute, Patna medical college and hospital, India

ABSTRACT

Introduction: Glioblastoma Multiforme [WHO grade IV glioma] still remains a dreadful diagnosis in oncology with the median survival ranging between 12 to 17 months, despite the recent advances in its management[11,12] It is the most common malignant primary tumour in adults[13]. The standard of care is Maximal Safe Resection followed by Concomitant ChemoRadiotherapy